Skip to Content
Morningstar

American Century Quality Dvrs Intl ETF QINT

Morningstar Medalist Rating
Medalist Rating as of | See American Century Investment Hub

Morningstar’s Analysis QINT

Will QINT outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

  • Process Pillar

    The Process Pillar is our assessment of how sensible, clearly defined, and repeatable QINT’s performance objective and investment process is for both security selection and portfolio construction.

  • People Pillar

    The People Pillar is our evaluation of the QINT management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.

  • Parent Pillar

    The Parent Pillar is our rating of QINT’s parent organization’s priorities and whether they’re in line with investors’ interests.

American Century Quality Dvrs Intl ETF’s management team is rated Average, but a solid investment process still helps this strategy retain its Morningstar Medalist Rating of Gold.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a sizable cost advantage over competitors, priced within the lowest fee quintile among peers.

by Morningstar Manager Research
Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings QINT

More QINT Holdings
  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 13.4
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Novo Nordisk A/S Class B

2.28 5.1 Mil
Healthcare

Novartis AG Registered Shares

1.35 3.0 Mil
Healthcare

Mitsubishi Corp

1.30 2.9 Mil
Industrials

Shell PLC

1.28 2.9 Mil
Energy

L'Oreal SA

1.27 2.9 Mil
Consumer Defensive

Hermes International SA

1.23 2.8 Mil
Consumer Cyclical

Denso Corp

1.22 2.7 Mil
Consumer Cyclical

Ferrari NV

1.20 2.7 Mil
Consumer Cyclical

Shin-Etsu Chemical Co Ltd

1.17 2.6 Mil
Basic Materials

Sanofi SA

1.10 2.5 Mil
Healthcare